PremiumThe FlyApplied Therapeutics reports FY24 EPS (76c), consensus ($1.33) Applied Therapeutics Delays Yearly Report Filing Applied Therapeutics files Form 12b-25 with SEC PremiumThe FlyNordstrom family to take chain private: Morning Buzz Pony AI, Thermo Fisher initiated: Wall Street’s top analyst calls Morning Movers: Despegar surges following deal to be acquired by Prosus PremiumThe FlyApplied Therapeutics appoints Johnson as Executive Chairman, CEO steps down Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP Edgewise should be bought on weakness as ARCH not likely FDA focus, says Truist 
